Covalent modification of ataxin-3 by SUMO-1

Progress in Biochemistry and Biophysics

Volumn 33, Issue 11, 2006, Pages 1037-1043

  Tang, Jian Guang ^a,b   Shen, Lu ^a   Tang, Bei Sha ^a   Zhang, Yu Hu ^a   Jiang, Hong ^a   Liao, Shu Sheng ^a   Zhang, Hai Nan ^b   Wang, Chun Yu ^b   Xia, Kun ^c   Pan, Qian ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c National Laboratory of Medical Genetics of China   (China)

Author keywords

Ataxin 3; Co immunoprecipitation; Immunofluorescence; Spinocerebellar ataxia type 3 and Machado Joseph disease(SCA3 MJD); SUMO 1; Yeast two hybrid

Indexed keywords

EID: 33947237836     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet, 1994, 8 (3): 221-228
2. Evert B O, Wullner U, Schulz J B, et al. High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum Mol Genet, 1999, 8 (7): 1169-1176
3. Warrick J M, Paulson H L, Gray-Board G L, et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell, 1998, 93 (6): 939-949
4. Gatchel J R, Zoghbi H Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet, 2005, 6 (10): 743-755
5. Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet, 2003, 12 (2): R173-186
6. Schols L, Amoiridis G, Buttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?. Ann Neurol, 1997, 42 (6): 924-932
7. Tang B, Liu C, Shen L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol, 2000, 57 (4): 540-544
8. Johnson E S. Protein modification by SUMO. Annu Rev Biochem, 2004, 73: 355-382
9. Klement I A, Skinner P J, Kaytor M D, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 1998, 95 (1): 41-53
10. Nucifora F C Jr, Ellerby L M, Wellington C L, et al. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem, 2003, 278 (15): 13047-13055
11. Cornett J, Cao F, Wang C E, et al. Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet, 2005, 37 (2): 198-204
12. Tait D, Riccio M, Sittler A, et al. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum Mol Genet, 1998, 7 (6): 991-997
13. Mantamadiotis T, Lemberger T, Bleckmann S C, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet, 2002, 31 (1): 47-54
14. Nucifora F C Jr, Sasaki M, Peters M F, et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science, 2001, 291 (5512): 2423-2428
15. Li F, Macfarlan T, Pittman R N, et al. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem, 2002, 277 (47): 45004-45012
16. Pascual G, Fong A L, Ogawa S, et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 2005, 437 (7059): 759-763
17. Jana N R, Nukina N. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway. J Chem Neuroanat, 2003, 26 (2): 95-101
18. Tsai Y C, Fishman P S, Thakor N V, et al. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem, 2003, 278 (24): 22044-22055.
19. Chang C C, Lin D Y, Fang H I, et al. Daxx mediates the SUMO-dependent transcriptional repression of Smad4. J Biol Chem, 2005, 280 (11): 10164-10173
20. Steffan J S, Agrawal N, Pallos J, et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science, 2004, 304 (5667): 100-104